About John Neczesny
Form D filings for Gemelli Biotech from 2022 to 2024 list John Neczesny as director.
John Neczesny first appears on SEC filings in 2022.
Experience
This experience comes from SEC filings. The years are when the filings name John Neczesny in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people John Neczesny works with at each company, as listed on that company's latest Form D.
Gemelli Biotech Corp. · Form D/A, Dec 2, 2024
MM
Matthew Mitcho
Chief Executive Officer and director
OL
Oded Levy
Director
RA
Ritish Agarwal
Director
JL
James Laur
Director